MRNA vs ZM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 08, 2026

MRNA

49.9
AI Score
VS
ZM Wins

ZM

60.4
AI Score

Investment Advisor Scores

MRNA

50score
Recommendation
HOLD

ZM

60score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric MRNA ZM Winner
Forward P/E 23.0415 18.7266 ZM
PEG Ratio 0 4.2142 Tie
Revenue Growth 260.2% 5.3% MRNA
Earnings Growth -85.1% 91.5% ZM
Tradestie Score 49.9/100 60.4/100 ZM
Profit Margin -143.6% 39.0% ZM
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY ZM

Frequently Asked Questions

Based on our detailed analysis, ZM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.